http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190088510-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f754fd795dc6b56d4d89fd74562d3d3 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564 |
| filingDate | 2017-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee6ca5eccf532e2e6b0ec64c55a85c88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de3b8f66b8b346d289d09930b08aaa66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f48d753392dd73b5020d145178598365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_629246b14a635a27642df19dfa590d56 |
| publicationDate | 2019-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20190088510-A |
| titleOfInvention | Antibody assay |
| abstract | The present invention relates to a method of detecting an antibody in a test sample containing a body fluid obtained from a mammalian subject to detect liver cancer in a mammalian subject, said antibody comprising a tumor marker protein selected from the group consisting of MMP9, AIF1, EpCAM and CDKN1B Wherein the test sample is contacted with a tumor marker antigen selected from the group consisting of MMP9, AIF1, EpCAM and CDKN1B and a tumor marker conjugated to autoantibodies in the test sample Determining the presence or absence of a complex of the antigen and presenting that the presence of the complex referred to herein indicates the presence of liver cancer. Also included within the invention are corresponding methods for diagnosing and treating liver cancer in mammalian subjects, corresponding methods for predicting response to anti-hepatoma treatment, corresponding methods for detecting antibodies in test samples containing body fluids obtained from mammalian subjects, And kits suitable for carrying out the methods of the present invention. |
| priorityDate | 2016-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 381.